Pure Global

INNO-LiPA HLA-C Line Probe Assay - Taiwan Registration 4acee8042362b6baa4f049f36a5e0556

Access comprehensive regulatory information for INNO-LiPA HLA-C Line Probe Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4acee8042362b6baa4f049f36a5e0556 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
4acee8042362b6baa4f049f36a5e0556
Registration Details
Taiwan FDA Registration: 4acee8042362b6baa4f049f36a5e0556
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

INNO-LiPA HLA-C Line Probe Assay
TW: ๅ› ่ซพ-็ซ‹ๅธ•ๆ ธ้…ธๆŽข้‡ๅผไบบ้กž็™ฝ่ก€็ƒๆŠ—ๅŽŸ่ฉฆๅŠ‘็ต„-Cไฝ้ปž
Risk Class 2
MD
Cancelled

Registration Details

4acee8042362b6baa4f049f36a5e0556

Ministry of Health Medical Device Import No. 027353

DHA05602735307

Company Information

Belgium

Product Details

B Hematology and pathology devices

B0001 Human leukocyte antigen segmentation board

Imported from abroad

Dates and Status

Jun 18, 2015

Jun 18, 2025

Oct 28, 2022

Cancellation Information

Logged out

ๅ…ฌๅธๆญ‡ๆฅญ